Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC)

Ball, D, Rischin, D, Burmeister, B, Mitchell, P, Boyer, M, MacManus, M and Walpole, E (2004). Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC). In: Lung Cancer. 9th Central European Lung Cancer Conference, Gdansk Poland, (S52-S53). Sep 23-25, 2004.

Author Ball, D
Rischin, D
Burmeister, B
Mitchell, P
Boyer, M
MacManus, M
Walpole, E
Title of paper Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy (RT) in patients with stage III non-small-cell lung cancer (NSCLC)
Conference name 9th Central European Lung Cancer Conference
Conference location Gdansk Poland
Conference dates Sep 23-25, 2004
Proceedings title Lung Cancer   Check publisher's open access policy
Journal name Lung Cancer   Check publisher's open access policy
Publisher ELSEVIER SCI IRELAND LTD
Publication Year 2004
Year available 2004
Sub-type Published abstract
Open Access Status Not Open Access
ISSN 0169-5002
Volume 45
Start page S52
End page S53
Total pages 2
Language eng
Keyword Oncology
Respiratory System
Oncology
Respiratory System
ONCOLOGY
RESPIRATORY SYSTEM
Q-Index Code EX
Institutional Status Non-UQ

Document type: Conference Paper
Sub-type: Lung Cancer
Collection: ResearcherID Downloads - Archived
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Thu, 04 Jul 2013, 02:20:59 EST by System User